3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Pseudomyxoma Peritonei
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pharyngeal Neoplasms
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurofibrosarcoma
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Interventions
Sufentanil
1
Bevacizumab
1
((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroma, Acoustic
×
Sirolimus
×
30 days
×
Clear all
No trials found.